Belpointe Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-845
Closed -$275K 957
2024
Q1
$275K Buy
+845
New +$207K 0.02% 624
2023
Q2
Sell
-170
Closed -$36.9K 3582
2023
Q1
$36.9K Sell
170
-380
-69% -$74K ﹤0.01% 1901
2022
Q4
$113K Buy
+550
New +$139K 0.01% 1176

Other funds holding SWAV

Belpointe Asset Management's SWAV Position: Q2 2024 in Review

Belpointe Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 845 shares — an estimated $275K sold.

Belpointe Asset Management first reported a position in SWAV in Q4 2022 and held it in 3 quarters. The position peaked at $275K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Belpointe Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Belpointe Asset Management sold 845 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $275K.
  • Belpointe Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Belpointe Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $275K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Belpointe Asset Management's 13F filing for Q2 2024, filed 2 Aug 2024.